NetworkNewsBreaks

WednesdayOct 20, 2021 1:49 pm

NetworkNewsBreaks – InnerScope Hearing Technologies Inc. (INND) Raises Buyers’ Interest, Showcases Unmatched Hearing Devices and Products During Recent Event

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the direct-to-consumer (“DTC”) hearing technology space, participated in the recent virtual Home Health & Diabetes Care Program — an event that connects sellers and corporate buyers. InnerScope raised buyers’ interest as the only company from the hearing device and hearing health care category to present at the event. During the event, the company showcased its broad range of unmatched direct-to-consumer hearing aids and accompanying products to corporate buyers from the home health care sector and some of the largest U.S. retailers, “including industry heavyweights such as CVS and Kroger…

Continue Reading

WednesdayOct 20, 2021 1:17 pm

NetworkNewsBreaks – Avricore Health Inc.’s (TSX.V: AVCR) (OTCQB: AVCRF) HealthTab(TM) Platform Helping Reduce Patient Care Costs, Waiting Time

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) understands that up to 70% of all medical decisions are based on lab tests, which account for between 3% and 6% of total patient-care costs. The amount can be even more significant if a patient requires multiple tests or if the initial test proves unforthcoming. Avricore — which is focused on developing a network of point-of-care analyzers, offering advanced technologies that aid with easy, fast and efficient diagnosis — utilizes its HealthTab(TM) platform in community pharmacies, rural areas and workplaces to cut down on the time it takes for a patient to get a…

Continue Reading

WednesdayOct 20, 2021 1:08 pm

NetworkNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Targeting Early 2022 Rollout of Carbon-Free NH3 Demonstration Programs

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) is looking to change the energy landscape through its flagship project, which entails using its proprietary, first-of-its-kind technology to produce carbon-free ammonia (“NH3”). The company aims to change the narrative around the current carbon-intense and energy-intense Haber-Bosch process of industrially synthesizing NH3. A recent article quotes NHHHF CEO Ian Clifford as saying, “Our system is entirely carbon-free… We take sustainable electricity, water and air, and we produce carbon-free NH3, which can be utilized across multiple industries as an extremely versatile material… We are now just in the process of commercializing the technology, and we plan…

Continue Reading

WednesdayOct 20, 2021 12:50 pm

NetworkNewsBreaks – Friendable Inc. (FDBL) Commences Digital Campaign to Promote Brand, Make Fan Pass a Household Name

Friendable (OTC: FDBL), a mobile technology and marketing company, recently released 15- and 30-second radio spots on Spotify and other programmatic networks as part of its 120-day strategy, which also included the release of version 2.0 of the Fan Pass platform. Following the release of the all-new version, Friendable took the necessary steps to ensure a stable platform and sound service offerings. “Now, it’s time to begin promoting our brand and mission with the release of these two radio spots, which are just beginning to run on various networks including Spotify,” a recent article quotes Friendable CEO Robert A. Rositano…

Continue Reading

WednesdayOct 20, 2021 12:16 pm

NetworkNewsBreaks – Save Foods Inc. (NASDAQ: SVFD) Announces Validation of Pre-Harvest Applications of Its Treatments by Leading California Academic Institution

Save Foods (NASDAQ: SVFD), an Israeli-based agrifood tech company focused on developing and selling eco-friendly products specifically designed to extend the shelf life and ensure the safety of fresh fruits and vegetables, today announced the completion of a series of successful trials in conjunction with a leading California academic institution. Save Foods is collaborating with several plant pathologists and researcher labs as part of its efforts to validate the efficacy of its products. Recently, a world-renowned academic institution in California validated the efficacy and impact of Save Foods’ treatments as a pre-harvest application. Results from the study demonstrate pre-harvest applications…

Continue Reading

WednesdayOct 20, 2021 11:06 am

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Study Reveals Effectiveness of Proprietary Drug-Development Tech

Lexaria Bioscience (NASDAQ: LEXX), developers of the revolutionary DehydraTECH(TM) drug-delivery technology, has released study results focused on THC-A21-1, a THC oral format. According to the announcement, the study showed that Lexaria’s DehydraTECH THC solution delivers THC levels to blood plasma an estimated three times faster than standard MCT-based THC. Based on study results, it took only 15 minutes using oral ingestion of the substance to reach THC levels comparable to those reached in 45 minutes using "coconut-oil" formulations. As the THC left the system at the six-hour mark, levels were comparable and demonstrated the fast-on, fast-off performance. The DehydraTECH results are timely…

Continue Reading

WednesdayOct 20, 2021 10:35 am

NetworkNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Granted Approval to Evaluate Sensory Factors in Product-Development Trials

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) has received an amendment to a cannabis research license it had previously been granted by Health Canada. The amendment allows the company to include sensory evaluations of cannabis beverages in an upcoming product development trial. According to the announcement, the company will be able to  conduct onsite human assessments of the taste, smell, feel and visual appeal of products the company is developing, a move that BevCanna says will provide significant advantages for its white-label clients as well as in-house brands because the new-product trial capabilities are unique in the Canadian cannabis beverage…

Continue Reading

TuesdayOct 19, 2021 3:40 pm

NetworkNewsBreaks – STRATTEC SECURITY CORP. (NASDAQ: STRT) Featured in Research Note from Sidoti

Earnings Preview; Estimates Lowered STRATTEC SECURITY (NASDAQ: STRT) was featured in a company-sponsored research note published by Sidoti & Company, LLC. The headline of the note reads, “Look For STRATTEC To Open F2022 On A Challenging Note Due To Supply Chain Disruptions; View Sustainability And Slope Of Recovery As Likely Investor Focus; Maintain $65 Price Target.” Click here to access the full report. About STRATTEC SECURITY CORPORATION STRATTEC designs, develops, manufactures, and markets automotive Access Control Products, including mechanical locks and keys, electronically enhanced locks and keys, steering column and instrument panel ignition lock housings, latches, power sliding side door systems,…

Continue Reading

TuesdayOct 19, 2021 3:38 pm

NetworkNewsBreaks – Hudson Global, Inc. (NASDAQ: HSON) Featured in Research Note from Sidoti

Earnings Preview Hudson Global (NASDAQ: HSON) was featured in a company-sponsored research note published by Sidoti & Company, LLC. The headline of the note reads, “HSON’s 1H:21 Business Wins, Growing Prospect Funnel Fuel Expectations For A Meaningful Lift In 3Q:21 Adjusted Net Revenue And EPS; Attractive Valuation, Robust Balance Sheet Support $31 PT.” Click here to access the full report. About Hudson Global, Inc. Hudson Global is a leading global total talent solutions provider operating under the brand name Hudson RPO. We deliver innovative, customized recruitment outsourcing and total talent solutions to organizations worldwide. Through our consultative approach, we develop tailored…

Continue Reading

TuesdayOct 19, 2021 3:03 pm

NetworkNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Impacting the Pharmaceutical Industry

Lexaria Bioscience Corp. (NASDAQ: LEXX) has remained committed to enhancing the speed and overall efficiency of orally delivered fat-soluble active molecules. The company is leveraging its drug delivery technology, DehydraTECH(TM), in the development of hypertension and anti-viral treatments — a big achievement already making an impact in the pharmaceutical industry. “Since Lexaria began working on this technology in 2014, DehydraTECH has developed considerably and impacted the industry. So far, it has proven useful for potentially treating hypertension, along with the delivery of colchicine, a drug with known SARS-CoV-2 anti-viral properties,” reads a recent article. “DehydraTECH is applied by incorporating an…

Continue Reading